PHINDER: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection

Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection.

Inova Fairfax Medical Campus
3300 Gallows Road
Falls Church, VA 22042

1. Males and females at least 18 years of age who give voluntary written informed consent to participate in the study.
2. Patients with diagnosis of ILD based on computed tommography imaging, including:
   1. Idiopathic interstitial pneumonia, inclusing idiophatic pulmonary fibrosis
   2. Connective tissue disease-associated ILD with FVC>70%
   3. Hypersensitivity pneumonitis
   4. Scleroderma-related ILD
   5. Autoimmune ILD
   6. Nonspecific interstitial pneumonia
   7. Occupational lung disease
   8. Combined pulmonary fibrosis and emphysema
3. Patients must meet at total of 2 or more criteria from at least 2 distinct categories below:
   1. Category 1: Clinical test
   2. Category 2: Symptoms, oxygenation, excercise capacity, and BNP/NT -proBNP

1. Prior RHC with mPAP >20mmHg
2. Currently on an FDA-Approve pulmonary arterial hypertension medication
3. Diagnosed with chronic obstructive pulmonary disease
4. Uncontrolled or untreated sleep apnea
5. Pulmonary embolism within the past 3 months